<< مقالات لاتين >>
<< بر اساس عنوان >>
1
CARDIOMYOPATHY IN PATIENTS INFECTED WITH HUMAN IMMUNE DEFICIENCY VIRUS.
2
Cardiomyopathy in rats with Walker 256 tumor: The potential role of microvascular disease in its genesis
3
Cardiomyopathy with a unique finding of bicuspid aortic valve in Beckerʹs muscular dystrophy
4
Cardiomyopathy with Pancytopenia in a Pregnancy: Case Reports
5
Cardiomyopathy, nephropathy, and death in a 44-year-old man
6
Cardiomyopathy: a role for nitric oxide?
7
Cardiomyoplasty — Improvement of Muscle Fibre Type Transformation by an Anabolic Steroid (Metenolone)
8
Cardiomyoplasty after implantation of a pacemaker and cardioverter/defibrillator
9
Cardiomyoplasty reduces myocardial oxygen consumption: implications for direct mechanical compression
10
Cardiomyoplasty: Is it time to wrap it up?
11
Cardiomyoplasty: the benefits of electrical prestimulation of the latissimus dorsi muscle in situ
12
Cardio-Oesophageal Reflex: Mechanism for “Linked Angina” in Patients with Angiographically Proven Coronary Artery Disease
13
Cardio-Oncology in Iran: Cardio-toxicity Registry
14
Cardiopetalolactone: A Novel Styryllactone from Goniothalamus cardiopetalus
15
Cardioplegia and Diazoxide Modulate STAT3 Activation and DNA Binding
16
Cardioplegia and ischemia in the canine heart evaluated by 31P magnetic resonance spectroscopy
17
Cardioplegia in pediatric cardiac surgery: do we believe in magic?
18
Cardioplegia preserves hypoxic response in isolated coronary arteries but not in isolated hearts
19
Cardioplegia protection against ischemia-reperfusion failure: Role of both modes of Na/Ca-exchanger and sarcoplasmic reticulum  
20
Cardioplegia-induced cell swelling: prevention by normothermic infusion
21
Cardioplegic arrest with image-arginine improves myocardial protection: results of a prospective randomized clinical trial
22
Cardioplegic ischemia or reperfusion: Which is a main trigger for tumor necrosis factor production?
23
Cardiopoiesis: Cardiac myocyte creation by adult and embryonic cells
24
Cardiopoietic Stem Cell Therapy in Heart Failure: The C-CURE (Cardiopoietic stem Cell therapy in heart failURE) Multicenter Randomized Trial With Lineage-Specified Biologics
25
Cardiopoietry in Motion: Primed Mesenchymal Stem Cells for Ischemic Cardiomyopathy
26
Cardioprotection and garlic
27
Cardioprotection and garlic
28
Cardioprotection and garlic
29
Cardioprotection and garlic
30
Cardioprotection and mitochondrial S-nitrosation: Effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia–reperfusion injury
31
Cardioprotection at a Distance: Mesenteric Artery Occlusion Protects the Myocardium via an Opioid Sensitive Mechanism
32
Cardioprotection before revascularization in ischemic myocardial injury and the potential role of hemoglobin-based oxygen carriers
33
Cardioprotection by 3-iodothyronamine, a new endogenous chemical messenger
34
Cardioprotection by Activation of NO/cGMP Pathway After Cardioplegic Arrest and 8-Hour Storage
35
Cardioprotection by Cyclosporine A in Experimental Ischemia and Reperfusion—Evidence for a Nitric Oxide-dependent Mechanism Mediated by Endothelin
36
Cardioprotection by Ischemic Preconditioning Preserves Mitochondrial Function and Functional Coupling Between Adenine Nucleotide Translocase and Creatine Kinase
37
Cardioprotection by Local Heating: Improved Myocardial Salvage After Ischemia and Reperfusion
38
Cardioprotection by Orotic Acid: Metabolism and Mechanism of Action
39
Cardioprotection by Volatile Anesthetics in Noncardiac Surgery? No, Not Yet At Least
40
Cardioprotection During Chemotherapy: Need for Faster Transfer of Knowledge From Cardiology to Oncology and Role for a Cardio-Oncologist
41
Cardioprotection Effects of Sevoflurane by Regulating the Pathway of Neuroactive Ligand-Receptor Interaction in Patients Undergoing Coronary Artery Bypass Graft Surgery
42
Cardioprotection for Duchenne’s muscular dystrophy, ,
43
Cardioprotection from ischaemia–reperfusion injury: Dissecting the PI3K/AKT pathway with chemical inhibition of PTEN
44
Cardioprotection in aged myocardium: Sites of failure in protective signalling
45
Cardioprotection induced in response to preconditioning is lost after an initral iscraemic insult
46
Cardioprotection of bradykinin at reperfusion in isolated rat hearts requires a transactivation of the EGF receptor
47
Cardioprotection of trimetazidine and anthracycline-induced acute cardiotoxic effects
48
Cardioprotection with phosphodiesterase-5 inhibition—a novel preconditioning strategy
49
Cardioprotection: A New Paradigm in the Management of Acute Heart Failure Syndromes
50
Cardioprotection: Intermittent Ventricular Fibrillation and Rapid Pacing Can Induce Preconditioning in the Blood-perfused Rat Heart
51
Cardioprotective Actions of Verapamil on theβ-Adrenergic Receptor Complex in Acute Canine Chagasʹ Disease
52
Cardioprotective activity of melatonin and its novel synthesized derivatives on doxorubicin-induced cardiotoxicity Original Research Article
53
Cardio-protective and anti-cancer therapeutic potential of Nigella sativa
54
Cardioprotective and antioxidant activities of a polysaccharide from the root bark of Aralia elata (Miq.) Seem
55
Cardioprotective and Anti-oxidant Effects of the Terpenoid Constituents ofGinkgo bilobaExtract (EGb 761)
56
Cardio-protective and cholesterol lowering effects of garlic (Allium sativum) and ginger (Zingiber officiale) extracts in laboratory animals
57
Cardioprotective and Hepatoprotective Activity of Silymarin in Broiler Chickens Fed on Mash and Pellet Diets
58
Cardioprotective and neuroprotective roles of oleuropein in olive
59
Cardioprotective and neuroprotective roles of oleuropein in olive
60
Cardioprotective Effect by Tumor Necrosis Factor-α and Interleukin-6 through Late Preconditioning in Unstable Angina Patients
61
Cardioprotective effect of aqueous extract of Chichorium intybus L. on ischemia-reperfusion injury in isolated rat heart
62
Cardioprotective effect of Azadirachta indica A. Juss. on isoprenaline induced myocardial infarction in rats
63
Cardioprotective Effect of Beta-3 Adrenergic Receptor Agonism: Role of Neuronal Nitric Oxide Synthase
64
Cardioprotective effect of cedrol in an inflammation systemic model induced by lipopolysaccharide: Biochemical and histological verification
65
Cardioprotective effect of chronic hypoxia is blunted by hypercapnia
66
Cardioprotective effect of chronic low dose ethanol drinking: Insights into the concept of ethanol preconditioning
67
Cardioprotective Effect of Cold-Blood Cardioplegia Enriched with N-Acetylcysteine During Coronary Artery Bypass Grafting
68
Cardioprotective effect of diazepam on ischemia-reperfused isolated hyperthyroid rat heart
69
Cardioprotective Effect of Ethanolic Leaf Extract of Melissa Officinalis L Against Regional Ischemia-Induced Arrhythmia and Heart Injury after Five Days of Reperfusion in Rats
70
Cardioprotective Effect of Extended Remote Ischemic Preconditioning in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Clinical Trial
71
Cardioprotective effect of fasting on ischemia reperfused rat heart after diazepam administration
72
Cardioprotective Effect of Garlic Juice on the Isolated Rat Heart in Ischemia- Reperfusion
73
Cardioprotective Effect of Glucagon Like Peptide-1 Receptor During Reperfusion of Isolated Ischemic Rat Heart Involves AMP-Activated Protein Kinase (AMPK) and Akt Signaling Pathways
74
Cardioprotective Effect of Grape Seed Extract on Chronic Doxorubicin-Induced Cardiac Toxicity in Wistar Rats
75
Cardioprotective effect of grape seed proanthocyanidins on isoproterenol-induced myocardial injury in rats
76
Cardioprotective effect of growth hormone secretagogues in rat heart
77
Cardioprotective Effect of High Intensity Interval Training and Nitric Oxide Metabolites (NO2-, NO3-)
78
Cardioprotective Effect of High-Intensity Aerobic Interval Training against Adriamycin-Induced Cardiac Toxicity in Rats
79
Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats
80
Cardioprotective effect of lipstatin derivative orlistat on normotensive rats submitted to cardiac ischemia and reperfusion
81
Cardioprotective effect of preconditioning is more efficient than postconditioning in rats submitted to cardiac ischemia and reperfusion
82
Cardioprotective Effect of Quercetin against Ischemia/Reperfusion Injury Is Mediated Through NO System and Mitochondrial KATP Channels
83
Cardioprotective effect of Rosa canina L. methanolic extract on heat shock induced cardiomyocyte injury: An experimental study
84
Cardioprotective effect of royal jelly on paclitaxel-induced cardio-toxicity in rats
85
Cardioprotective Effect of Saffron Extract and Safranal in Isoproterenol-Induced Myocardial Infarction in Wistar Rats
86
Cardioprotective effect of selenium via modulation of cardiac ryanodine receptor calcium release channels in diabetic rat cardiomyocytes through thioredoxin system
87
Cardioprotective effect of vanillic acid against doxorubicin-induced cardiotoxicity in rat
88
CARDIOPROTECTIVE EFFECTS AND MECHANISM OF ACTION OF POLYPHENOLS EXTRACTED FROM PROPOLIS AGAINST DOXORUBICIN TOXICITY
89
Cardioprotective effects and molecular mechanisms of G-CSF on LV remodeling and dysfunction after AMI
90
Cardioprotective Effects of 17β-Estradiol Produced by Activation of Mitochondrial ATP-Sensitive K+Channels in Canine Hearts
91
Cardioprotective effects of a proanthocyanidin-rich fraction from Croton celtidifolius Baill: Focus on atherosclerosis
92
Cardioprotective effects of an early invasive strategy for non–ST-segment elevationacute coronary syndromes: Are we all becoming “interventional” cardiologists?
93
Cardioprotective effects of atorvastatin plus trimetazidine in percutaneous coronary intervention
94
Cardioprotective effects of bosentan, a mixed ETA/ETB Receptor antagonist on myocardial ischemic and reperfusion injury in cats
95
Cardioprotective effects of co-administration of thymoquinone and ischemic postconditioning in diabetic rats
96
Cardioprotective Effects of Coenzyme Q10 Supplementation on Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
97
Cardioprotective Effects of Curcumin Co-treatment in Rats With Establishing Chronic Variable Stress Stereology Study
98
Cardioprotective Effects of Essential Oil of Lavandula angustifolia on Isoproterenol-induced Acute Myocardial Infarction in Rat
99
Cardioprotective effects of Fenugreek (Trigonella foenum-graceum) seed extract in streptozotocin induced diabetic rats
100
Cardioprotective effects of FK409, a nitric oxide donor, after isolated rat heart preservation for 16 hours
101
Cardioprotective effects of Ganoderma lucidum on isoproterenol–induced heart failure
102
Cardioprotective effects of granulocyte colony-stimulating factor in swine with chronic myocardial ischemia
103
Cardioprotective Effects of Granulocyte Colony-Stimulating Factor in Swine With Chronic Myocardial Ischemia Original Research Article
104
Cardioprotective Effects of Grape Seed Proanthocyanidin Against Ischemic Reperfusion Injury
105
Cardioprotective effects of Ilex paraguariensis extract: evidence for a nitric oxide-dependent mechanism
106
Cardioprotective effects of iroxanadine: Role of nitric oxide, reactive oxygen species and heat-shock proteins
107
cardioprotective effects of mebudipine in a rat model of doxorubicin-induced heart failure
108
Cardioprotective Effects of Methanolic Extract of Scrophularia frigida on Ischemia-Reperfusion-Induced Injuries in Isolated Rat Heart
109
cardioprotective effects of octreotide against sepsis-induced cardiotoxicity in mice
110
Cardioprotective effects of pharmacologic preconditioning by natural honey against ischemia/reperfusion injury
111
Cardioprotective effects of pomegranate juice against ischemia and reperfusion in isolated rat heart
112
Cardioprotective Effects of Potassium Channel Openers on Rat Atria and Isolated Hearts under Acute Hypoxia
113
Cardioprotective effects of preinfarction angina in elderly: same patients, different results?
114
Cardioprotective Effects of Rosmarinic Acid on IsoproterenolInduced Myocardial Infarction in Rats
115
Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention
116
Cardioprotective effects of the NHE1-inhibitor EMD 87580
117
Cardioprotective efficacy of ischemic preconditioning on long-term myocardial ischemia
118
Cardioprotective Function of Inducible Nitric Oxide Synthase and Role of Nitric Oxide in Myocardial Ischemia and Preconditioning: an Overview of a Decade of Research
119
Cardioprotective mechanisms of sour cherry seed extract against ischemia/reperfusion-induced damage in isolated rat hearts  
120
Cardioprotective Medication Is Associated With Improved Survival in Patients With Peripheral Arterial Disease Original Research Article
121
Cardioprotective Potential of Antihypertensives
122
Cardioprotective potential of biobased gold nanoparticles
123
Cardioprotective Potential of Celastrol in Sepsis-Induced Cardiotoxicity; Mouse Model of Endotoxemia
124
Cardioprotective Potential of Gemmomodified Extract of Terminalia arjuna against Chemically Induced Myocardial Injury in Rabbits
125
Cardio-protective properties of Momordica charantia in Albino Rats
126
Cardioprotective role of biosynthesized gold nanoparticles compared to an iodinated-based x-ray contrast agent in Male Wistar Rats
127
Cardioprotective role of FGF2 in a murine model of low-flow ischemia  
128
Cardio-Protective Role of Gingerol along with Prominent Anti-Diabetic Cardiomyopathy Action in A Streptozotocin-Induced Diabetes Mellitus Rat Model StreptozotocinInduced Diabetes Mellitus Rat Model
129
Cardioprotective therapy and sodium-hydrogen exchange inhibition: current concepts and future goals
130
Cardiopulmonary and Systemic Effects of Methylprednisolone in Patients Undergoing Cardiac Surgery
131
Cardiopulmonary Arrest Outcome in Nemazee Hospital, Southern Iran
132
CARDIOPULMONARY ARREST SECONDARY TO HALOPERIDOL
133
CARDIO-PULMONARY ASSESSMENT IN PATIENTS WITH BETA THALASSEMIA
134
Cardiopulmonary bypass affects cognitive brain function after coronary artery bypass grafting
135
Cardiopulmonary Bypass Alone Does Not Cause Postoperative Cognitive Dysfunction Following Open Heart Surgery
136
Cardiopulmonary bypass alters vasomotor regulation of the skeletal muscle microcirculation
137
Cardiopulmonary bypass and oxygen consumption: oxygen delivery and hemodynamics
138
Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans
139
Cardiopulmonary Bypass Circuit Treated With Surface-Modifying Additives: A Clinical Evaluation of Blood Compatibility
140
Cardiopulmonary bypass during pregnancy
141
Cardiopulmonary bypass for resuscitation after penetrating cardiac trauma
142
Cardiopulmonary bypass in a gravid patient: perioperative changes in endothelin levels
143
Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant
144
Cardiopulmonary bypass in humans: bypassing unfractionated heparin
145
Cardiopulmonary bypass in man: role of the intestine in a self-limiting inflammatory response with demonstrable bacterial translocation
146
Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis
147
Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using org 10172
148
Cardiopulmonary bypass in pregnancy
149
Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases
150
Cardiopulmonary bypass perfusion temperature does not influence perioperative renal function
151
Cardiopulmonary bypass support for emergency cesarean delivery in a patient with severe pulmonary hypertension
152
Cardiopulmonary bypass temperature, hematocrit, and cerebral oxygen delivery in humans
153
Cardiopulmonary Bypass Time Does Not Affect Cerebral Blood Flow
154
Cardiopulmonary Bypass With Bivalirudin in Type II Heparin-Induced Thrombocytopenia
155
Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia
156
Cardiopulmonary Bypass With Heparin-Coated Circuits and Reduced Systemic Anticoagulation
157
Cardiopulmonary Bypass, Inflammation and How to Defy it: Focus on Pharmacological Interventions
158
Cardiopulmonary bypass, rewarming, and central nervous system dysfunction
159
Cardiopulmonary bypass: Perioperative cerebral blood flow and postoperative cognitive deficit
160
Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital
161
Cardiopulmonary effects of Detomidine-Propofol and Ketamine administration in the Donkeys
162
Cardiopulmonary effects of dorsal recumbency and high-volume caudal epidural anaesthesia with lidocaine or xylazine in calves
163
Cardiopulmonary effects of HI-6 treatment in soman intoxication
164
Cardiopulmonary effects of the anesthesia by romifidine as a premedication, midazolam and ketamine induction and infusion in donkeys
165
Cardiopulmonary effects of the laparoscopic pneumoperitoneum in a porcine model of adult respiratory distress syndrome
166
Cardiopulmonary exercise parameters in relation to all-cause mortality in patients with chronic heart failure
167
Cardiopulmonary exercise test evidence of isolated right coronary artery disease
168
Cardiopulmonary Exercise Test in Advanced Heart Failure Among Heart Transplantation Candidates
169
Cardiopulmonary exercise test in patients with subacute pulmonary emboli
170
Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited
171
Cardiopulmonary Exercise Testing and Six-Minute Walk Correlations in Pulmonary Arterial Hypertension
172
Cardiopulmonary exercise testing before and one year after mitral valve repair for severe mitral regurgitation
173
Cardiopulmonary Exercise Testing Determination of Functional Capacity in Mitral Regurgitation: Physiologic and Outcome Implications Original Research Article
174
Cardiopulmonary Exercise Testing Identifies Low Risk Patients With Heart Failure and Severely Impaired Exercise Capacity Considered for Heart Transplantation
175
Cardiopulmonary exercise testing in patients with heart failure
176
Cardiopulmonary Exercise Testing in the Clinical and Prognostic Assessment of Diastolic Heart Failure Original Research Article
177
Cardiopulmonary Exercise Variables in Diastolic Versus Systolic Heart Failure
178
Cardiopulmonary Function at Rest and During Exercise After Resection for Bronchial Carcinoma
179
Cardiopulmonary function in adult patients late after Fontan repair
180
Cardiopulmonary Functions of School Children in Oil-Spilled and Gas-Flared Niger- Delta and Rural-Riverine Lagos Communities
181
Cardiopulmonary hazards of perihepatic packing for major liver injuries,
182
Cardiopulmonary helminth parasites of red foxes (Vulpes vulpes) in Catalonia, northeastern Spain
183
Cardiopulmonary Limited Ultrasound Examination for “Quick-Look” Bedside Application
184
Cardiopulmonary Mortalities and Chronic Obstructive Pulmonary Disease Attributed to Ozone Air Pollution
185
Cardiopulmonary Mortalities and Chronic Obstructive Pulmonary Disease Attributed to Ozone Air Pollution
186
Cardiopulmonary mortality and air pollution
187
Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide
188
Cardiopulmonary Rehabilitation for Patients with Coronavirus Disease 2019 (COVID-19): A Narrative Review
189
Cardiopulmonary Response to Exercise and Cardiac Assessment in Patients With Turner Syndrome
190
Cardiopulmonary response to maximal exercise in young athletes following the Ross procedure
191
Cardiopulmonary Responses to Exercise and Its Utility in Patients With Aortic Stenosis
192
Cardiopulmonary responses to robotic end-effector-based walking and stair climbing
193
Cardiopulmonary Resuscitation (CPR) and Its Ethical Aspects
194
CARDIOPULMONARY RESUSCITATION : THE SHORT COMINGS IN MALAYSIA
195
Cardiopulmonary resuscitation and neurological complications in the elderly
196
Cardiopulmonary resuscitation by bystanders with chest compression only (SOS-KANTO): an observational study
197
Cardiopulmonary resuscitation by Emergency Medical Services in South Africa: Barriers to achieving high quality performance
198
Cardiopulmonary resuscitation directives on admission to intensive-care unit: an international observational study
199
Cardiopulmonary resuscitation in nursing homes
200
CARDIOPULMONARY RESUSCITATION IN THE LIGHT OFNEW 2010 AMERICAN HEART ASSOCIATION GUIDELINES: A SURVEY AMONG HEALTHCARE PROFESSIONALS OF TERTIARY CARE HOSPITALS IN PESHAWAR CITY
201
Cardiopulmonary resuscitation knowledge among nursing students: a questionnaire study
202
Cardiopulmonary resuscitation knowledge among nursing students: a questionnaire-based study
203
Cardiopulmonary Resuscitation Outcomes of Patients with COVID-19; a One-Year Survey
204
Cardiopulmonary Resuscitation Techniques and Instruction: When Does Evidence Justify Revision?, ,
205
Cardiopulmonary Resuscitation to Cardiocerebral Resuscitation: Difference Is Small for Statistical Significance but Large for Clinical Relevance
206
cardiopulmonary resuscitation training for medical students in anesthesiology rotation in ardabil medical university (iran)
207
Cardiopulmonary resuscitation with a novel chest compression device in a porcine model of cardiac arrest: Improved hemodynamics and mechanisms Original Research Article
208
Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis
209
Cardiopulmonary Resuscitation, Chest Compression Only and Teamwork From the Perspective of Medical Doctors, Surgeons and Anesthesiologists
210
Cardiopulmonary resuscitation, ventilation, defibrillation: In what order?
211
Cardiopulmonary Resuscitation.J.P. Ornato and M.A. Peberdy, Editors, Humana Press (2005) 764 pages, $185 ISBN 1-58829-283-5.
212
Cardiopulmonary resuscitation: Historical perspective to recent investigations
213
Cardiopulmonary resuscitation: Knowledge and personal experience among dentists in Udaipur, India
214
Cardiopulmonary Safety of Propofol Versus Midazolam/Meperidine Sedation for Colonoscopy: A Prospective, Randomized, Double-Blinded Study
215
Cardiopulmonary-Cerebral Resuscitation (CPCR) Training for Nurses in Iran: A Review Study
216
Cardiorenal and sympathetic effects of leptin in spontaneously hypertensive lean and obese koletsky rats
217
Cardiorenal Anemia Syndrome as a Prognosticator for Death in Heart Failure
218
Cardiorenal Effects of Recombinant Human Natriuretic Peptides
219
Cardiorenal Interactions: Insights From the ESCAPE Trial Original Research Article
220
Cardiorenal Outcomes After Slow Continuous Ultrafiltration Therapy in Refractory Patients With Advanced Decompensated Heart Failure
221
Cardio-Renal Profiling with hs-CRP and its Implications as a Diagnostic Tool in Chronic Kidney Disease Patients.
222
Cardiorenal Protective Effects of Year-Long Antihypertensive Therapy With a Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker in Spontaneously Hypertensive Rats
223
Cardiorenal syndrome
224
Cardiorenal Syndrome
225
Cardiorenal Syndrome Review Article
226
Cardiorenal syndrome followed by acute hepatitis C in a patient with acute myeloid leukemia
227
Cardiorenal Syndrome or Renocardiac Syndrome
228
Cardiorenal Syndrome Type 1: Pathophysiological Crosstalk Leading to Combined Heart and Kidney Dysfunction in the Setting of Acutely Decompensated Heart Failure
229
Cardio-renal-anemia syndrome: a report of three cases
230
Cardiorespiratory and all-cause mortality after restrictions on sulphur content of fuel in Hong Kong: an intervention study
231
Cardiorespiratory and neuroendocrine changes induced by methadone in conscious and in isoflurane anaesthetised dogs
232
Cardiorespiratory and thermoregulatory effects of endophyte-infected fescue in exercising horses
233
Cardiorespiratory challenges in Rettʹs syndrome
234
Cardiorespiratory changes during upper gastrointestinal endoscopy
235
Cardio-respiratory control during early development in the model animal zebrafish
236
Cardio-respiratory coupling in untreated patients with major depression
237
CARDIORESPIRATORY CRISIS AT THE END OF PREGNANCY: A CASE OF PHEOCHROMOCYTOMA
238
Cardiorespiratory effects of epidurally administered ketamine or lidocaine in dogs undergoing ovariohysterectomy surgery: a comparative study
239
Cardiorespiratory Fitness and Body Composition of Soccer Referees; Do These Correlate With Proper Performance?
240
Cardiorespiratory fitness and coronary heart disease risk factor association in women
241
Cardiorespiratory Fitness and Its Relationship with Health Risk Factors Among University Students: A Comparison Between Iran and Italy
242
Cardiorespiratory Fitness and Metabolic Risk
243
Cardiorespiratory Fitness and Physical Literacy: Exploring the Nexus. A Scoping Review
244
Cardiorespiratory Fitness and Risk of Nonfatal Cardiovascular Disease in Women and Men With Hypertension
245
Cardiorespiratory fitness and risk of prostate cancer: Findings from the Aerobics Center Longitudinal Study
246
Cardiorespiratory Fitness and the Attenuation of Age-Related Rise in Blood Pressure: An Important Role for Effective Primordial Prevention
247
Cardiorespiratory Fitness as a Correlate of Cardiovascular, Anthropometric, and Physical Risk Factors: Using the Ruffier Test as a Template
248
Cardiorespiratory Fitness as Criterion Validity for Health-Based Metabolic Syndrome Definition in Adolescents
249
Cardiorespiratory Fitness Is Related to the Risk of Sudden Cardiac Death: A Population-Based Follow-Up Study
250
Cardio-respiratory fitness markers among Kenyan university students using a 20m shuttle run test (SRT)
251
Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men
252
Cardiorespiratory Parameters in Intermittent Positive Pressure Ventilation Versus Spontaneous Ventilation in Under One-Year-Old Pediatrics: A Randomized Trial
253
Cardiorespiratory reflexes in a working heart–brainstem preparation of the house musk shrew, Suncus murinus
254
Cardiorespiratory response during exercise in patients with cyanotic congenital heart disease with and without a Fontan operation and in patients with congestive heart failure
255
Cardiorespiratory Response to Exercise After Modified Fontan Operation: Determinants of Performance
256
Cardiorespiratory Response to Exercise After Renal Sympathetic Denervation in Patients With Resistant Hypertension
257
Cardiorespiratory responses to exercise after repair of the univentricular heart
258
Cardiorespiratory Responses to Glittre ADL Test in Bronchiectasis: A Cross-Sectional Study
259
Cardiorespiratory responses to negative pressure ventilation after tetralogy of Fallot repair: hemodynamic tool for patients with low-output state
260
Cardiorespiratory Responses to Table Tennis in Low-Fit Coronary Patients and Implications for Exercise Training
261
Cardiorotective effects of a novel indole derivative with antioxidant properties against ischemic reperfusion injury
262
Cardioscopic guidance of linear lesion creation for radiofrequency ablation
263
Cardioscopic spectrum of the left ventricular endocardial surface and its relation to histologic changes in idiopathic myocarditis
264
CardioSEAL/STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defects
265
CardioSignal: A database of transcriptional regulation in cardiac development and hypertrophy
266
Cardiosource is a good source for definition of trial acronyms
267
Cardiospermum halicacabum Linn.: Food and Drug
268
Cardiothoracic Surgeons Divided By a Common Language
269
Cardiothoracic surgery in the new millennium: challenges and opportunities in a time of paradox
270
Cardiothoracic Surgery Resident Education: Update on Resident Recruitment and Job Placement
271
Cardiothoracic Surgery, 2nd Edition: by Fritz J. Baumgartner, MD, Georgetown, Texas, Landes Bioscience, 1999, 280 pages, spiral bound, $45, ISBN: 1-570-59559-3
272
Cardiothoracic surgery: a specialty in transition—good to great?
273
Cardiotin localization in mitochondria of cardiomyocytes in vivo and in vitro and its down-regulation during dedifferentiation
274
Cardiotocography and medicolegal issues
275
Cardiotocography in the Prognosis of Perinatal Outcome
276
Cardiotocography only versus cardiotocography plus PR-interval analysis in intrapartum surveillance: a randomised, multicentre trial Original Research Article
277
Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial
278
Cardiotocography Waveform Analysis Using Image Extraction Technique
279
Cardiotomy Suction: A Major Source of Brain Lipid Emboli During Cardiopulmonary Bypass
280
Cardiotonic activity of methanolic extract of Saussurea lappa Linn roots
281
Cardiotonic Drugs from the Avicenna's Point of View
282
Cardiotonic Modulation in Heart Failure: Insights From Traditional Chinese Medicine
283
Cardiotoxic and Arrhythmogenic Effects of Hemiscorpius lepturus Scorpion Venom in Rats
284
Cardiotoxic Effects of Hemiscorpius Lepturus Scorpion Venom Fractions in Rats
285
Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy
286
Cardiotoxicité de l’association trastuzumab–radiothérapie mammaire : une étude prospective monocentrique
287
Cardiotoxicité de l’association trastuzumab–radiothérapie mammaire : une étude prospective monocentrique
288
Cardiotoxicity associated with sunitinib
289
Cardiotoxicity associated with sunitinib
290
Cardiotoxicity associated with sunitinib – Authorsʹ reply
291
Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer
292
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
293
Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors
294
Cardiotoxicity of 5-flourouracil: two case reports
295
Cardiotoxicity of cytotoxic drugs
296
Cardiotoxicity of Plants in Iran: a Review
297
Cardiotoxicity of Senna occidentalis in sheep (Ovis aries)
298
Cardiotoxicity Research in Breast Cancer Patients: Past and Future
299
Cardiotoxicity With 5-Fluorouracil Based Agents: Rechallenge Cannot Currently Be Safely Advised
300
Cardiotoxicity with adjuvant trastuzumab use in breast cancer: A single institution’s experience
301
Cardiotrophin-1 in Patients with Acute Myocardial Infarction
302
Cardiotrophin-1 Induces Heat Shock Protein Accumulation in Cultured Cardiac Cells and Protects them from Stressful Stimuli
303
Cardiotrophin-1 induces proliferation and activation of primary adult rat cardiac fibroblasts  
304
Cardiotrophin-1 is a prophylactic against the development of chronic hypoxic pulmonary hypertension in rats
305
Cardiotrophin-1 Phosphorylates Akt and BAD, and Prolongs Cell Survival via a PI3K-dependent Pathway in Cardiac Myocytes
306
Cardiotrophin-1 regulates osteoclast and osteoblast function in a manner distinct from other gp130 cytokines
307
Cardiovacular and cerebrovacular mortality aociated with ocular peudoexfoliation
308
Cardiovacular Dieae, it Rik Factor and Treatment, and Age-related Macular Degeneration: Women’ Health Initiative ight Exam Ancillary tudy
309
Cardiovacular Dieae, it Rik Factor and Treatment, and Age-related Macular Degeneration: Women’ Health Initiative ight Exam Ancillary tudy Original Reearch Article
310
Cardiovacular Rik Factor and Age-related Macular Degeneration: The Lo Angele Latino Eye tudy Original Reearch Article
311
Cardiovascular Abnormalities in Cirrhosis: the Possible Mechanisms
312
Cardiovascular Abnormalities in Hyperthyroidism
313
Cardiovascular abnormalities in hyperthyroidism
314
Cardiovascular Abnormalities in Hyperthyroidism
315
Cardiovascular abnormalities in hyperthyroidism: A prospective Doppler echocardiographic study
316
Cardiovascular abnormalities in never-treated hypertensives according to nondipper status
317
Cardiovascular Abnormalities in Sickle Cell Disease
318
Cardiovascular activity and the antibody response to vaccination
319
Cardiovascular adaptations to endurance training and detraining in young and older athletes
320
Cardiovascular aging and psychometric performances: correlations in a group of ultraseptagenarian elderly
321
Cardiovascular Aging: What We Can Learn From Caloric Restriction
322
Cardiovascular and Antioxidant Effects of the Methanol Extract From the Stem Bark of Erythrina Senegalensis DC (Fabaceae)
323
Cardiovascular and autonomic nervous functions during acclimatization to hypoxia in conscious rats
324
Cardiovascular and behavioural components of conditioned fear to context after ganglionic and α-adrenergic blockade
325
Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)
326
Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment
327
Cardiovascular and endocrine responses to cutaneous electrical stimulation after fentanyl in the ovine fetus
328
Cardiovascular and metabolic effects of the vasopeptidase inhibitor, omapatrilat in spontaneously hypertensive rats
329
Cardiovascular and metabolic responses to two receptor-selective opioid agonists in pregnant sheep
330
Cardiovascular and Metabolic Risk Factors: How Can We Improve Outcomes in the High-Risk Patient?
331
Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68–102: The cardiovascular Health Study
332
Cardiovascular and muscle activity during chewing in whiplash-associated disorders (WAD)
333
Cardiovascular and psychosomatic symptoms among relatives of patients waiting for possible coronary revascularization
334
Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review
335
Cardiovascular and renal disease in the adolescent guinea pig after chronic placental insufficiency
336
Cardiovascular and renal effects of a collagen cross-link breaker (ALT 711) in adult and aged spontaneously hypertensive rats
337
Cardiovascular and Renal Effects of Hibiscus Sabdariffa Linnaeus. in Patients with Diabetic Nephropathy: A Randomized, Double-Blind, Controlled Trial
338
Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension
339
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture
340
Cardiovascular and Respiratory Effects of Romifidine and/or Xylazine in Ketamine Anaesthesia in Dog: An Experimental Study
341
Cardiovascular and respiratory emergency dispatch due to shortterm exposure to ambient PM10 in Dezful, Iran
342
Cardiovascular and respiratory response to ascent of the Damavand summit by classic method in elite climbers
343
Cardiovascular and Systemic MicrovascularEffects of Anti-Vascular Endothelial Growth Factor Therapy for Cancer
344
Cardiovascular and ventilatory control during exercise in chronic heart failure: Role of muscle reflexes
345
Cardiovascular anomalies associated with chromosome 22q11.2 deletion
346
Cardiovascular Anomalies Associated With Chromosome 22q11.2 Deletion Syndrome
347
Cardiovascular anomalies in patients with chromosome 22q11.2 deletion: A Korean multicenter study
348
Cardiovascular applications for artifical structural proteins produced by recombinant technologies
349
Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS
350
Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease
351
Cardiovascular autonomic function in healthy adolescents
352
Cardiovascular autonomic function testing in asymptomatic T. cruzi carriers: a sensitive method to identify subclinical Chagasʹ disease
353
Cardiovascular autonomic function tests in type 2 diabetes mellitus with micro albuminuria
354
Cardiovascular autonomic modulation by nitric oxide synthases accounts for the augmented enalapril-evoked hypotension in ethanol-fed female rats
355
Cardiovascular autonomic nervous response to postural change in 610 healthy Japanese subjects in relation to age
356
Cardiovascular autonomic neuropathy in rheumatoid arthritis assessed by cardiovascular autonomic function tests: A cross-sectional survey
357
Cardiovascular autonomic regulation in Non-Obese Diabetic (NOD) mice
358
Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes
359
Cardiovascular benefits of nuts
360
Cardiovascular Care Facts: A Report From the National Cardiovascular Data Registry: 2011
361
Cardiovascular cavitation
362
Cardiovascular changes during induced emotion: An application of langʹs theory of emotional imagery
363
Cardiovascular changes in response to ovarian stimulation
364
Cardiovascular Characteristics in American Youth With Prehypertension
365
Cardiovascular characterization of Pkd2+/LacZ mice, an animal model for the autosomal dominant polycystic kidney disease type 2 (ADPKD2)
366
Cardiovascular complications and acute ischemic stroke after the treatment with epinephrine in an anaphylactic patient
367
Cardiovascular Complications in Infants of Diabetic Mothers: An Observational Study in a Pediatric Cardiology Clinic in Tehran
368
Cardiovascular Complications in Obstructive Sleep Apnea Syndrome
369
Cardiovascular complications in patients with megaesophagus due to Chagas disease undergoing the Serra-Dَria operation
370
Cardiovascular Complications of Cancer Therapy: Incidence, Pathogenesis, Diagnosis, and Management
371
Cardiovascular Complications of Chronic Opium Consumption: A Narrative Review Article
372
Cardiovascular Complications of COVID-19 in Patients With Multiple Sclerosis: A Lesson From Our Experience
373
Cardiovascular Complications of Direct Laryngoscopy vs Video Laryngoscopy in Patients over 65 Years Old
374
Cardiovascular complications of malignant carcinoid disease, ,
375
Cardiovascular Complications of Radiotherapy
376
Cardiovascular Complications of the Guillain-Barré Syndrome
377
Cardiovascular Conditions in Patients With Aluminum Phosphide Poisoning
378
Cardiovascular consequences of laparoscopic surgery
379
Cardiovascular consequences of sleep apnea: I -Epidemiology
380
Cardiovascular consequences of sleep apnea: II-Cardiovascular mechanisms
381
Cardiovascular consequences of sleep apnea: III-Impact of continuous positive airway pressure treatment
382
Cardiovascular Considerations in Antidepressant Therapy: An Evidence-Based Review
383
Cardiovascular control and plasma catecholamines during rest and mental stress: effects of posture
384
Cardiovascular control in Antarctic fish
385
Cardiovascular data on sildenafil citrate: Introduction
386
Cardiovascular Death and Cancer Death—Competing Risk?
387
Cardiovascular death from panic disorder and panic-like anxiety: A critical review of the literature
388
Cardiovascular determinants of plasma fibronectin in an elderly population: The EVA study
389
Cardiovascular disease
390
Cardiovascular Disease Among International Travellers
391
Cardiovascular disease among Mexican Americans
392
Cardiovascular disease and bone
393
Cardiovascular disease and chronic kidney disease: Insights and an update
394
Cardiovascular disease and cognitive performance in middle-aged and elderly men
395
Cardiovascular disease and mortality in statin-treated patients with familial hypercholesterolemia
396
Cardiovascular disease and neoplasms after pancreas transplantation
397
Cardiovascular disease and neoplasms after pancreas transplantation
398
Cardiovascular disease and neoplasms after pancreas transplantation
399
Cardiovascular Disease and Olympic Games in China
400
Cardiovascular disease and risk factors among 345 adults in rural India—the Andhra Pradesh Rural Health Initiative
401
Cardiovascular disease and risk factors in adults with hypopituitarism
402
Cardiovascular disease and risk factors in Montana American Indians and non-Indians Original Research Article
403
Cardiovascular disease and risk factors in patients with type 2 diabetes mellitus in Mashhad, Islamic Republic of Iran
404
Cardiovascular Disease and Risk in Primary Care Settings in the United States
405
Cardiovascular disease and sexual functioning
406
Cardiovascular disease and sleep-related erections
407
Cardiovascular disease and the global tobacco epidemic: a wake-up call for cardiologists
408
Cardiovascular disease burden shifts
409
Cardiovascular disease detection using bio-sensing techniques
410
Cardiovascular disease events and its predictors in women: Isfahan Cohort Study (ICS)
411
Cardiovascular Disease in Adult and Pediatric HIV/AIDS
412
Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan
413
Cardiovascular Disease in Asian Americans: Unmasking Heterogeneity
414
Cardiovascular disease in Chinese type 2 diabetic women is associated with a prolonged QTc interval
415
Cardiovascular Disease in Chronic Renal Failure Patients
416
Cardiovascular disease in familial hypercholesterolaemia: Influence of low-density lipoprotein receptor mutation type and classic risk factors
417
Cardiovascular disease in Hajj pilgrims
418
Cardiovascular disease in HIV infection
419
Cardiovascular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention
420
Cardiovascular disease in Latin America
421
Cardiovascular disease in lupus patients: Should all patients be treated with statins and aspirin?
422
Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria Original Research Article
423
Cardiovascular disease in older people
424
Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan Canada: Cardiovascular Disease in COPD Patients
425
Cardiovascular disease in patients with chronic renal failure
426
Cardiovascular disease in patients with end-stage renal disease on hemodialysis in a developing country
427
Cardiovascular disease in persons with depressive and anxiety disorders
428
Cardiovascular disease in postmenopausal women: myths and reality
429
Cardiovascular disease in rheumatoid arthritis
430
Cardiovascular disease in South Asians
431
Cardiovascular disease in South Asians
432
Cardiovascular Disease in the Developing World: Prevalences, Patterns, and the Potential of Early Disease Detection
433
Cardiovascular disease in the NHANES III
434
Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives
435
Cardiovascular disease in the tropics, ethics, and need for action
436
Cardiovascular Disease Knowledge among Cardiac Rehabilitation Patients in Eastern Iran: A Cross-Sectional Study
437
Cardiovascular disease knowledge among culturally Deaf patients in Chicago
438
Cardiovascular Disease Mortality and Years of Life Lost Attributable to Non-optimal Systolic Blood Pressure and Hypertension in Northeastern Iran
439
Cardiovascular Disease Mortality in Asian Americans
440
Cardiovascular Disease Mortality in Hispanics and Non-Hispanic Whites
441
Cardiovascular Disease Patient's Quality of Life in Tabriz City in Iran in 2018
442
Cardiovascular Disease Prevention among Youth: Visioning the Future
443
Cardiovascular Disease Prevention for Women Attending Breast and Cervical Cancer Screening Programs: The WISEWOMAN Projects
444
Cardiovascular Disease Prevention in Eastern Europe
445
Cardiovascular disease prevention in Russia: Challenges and opportunities
446
Cardiovascular Disease Prevention Research at the National Heart, Lung, and Blood Institute
447
Cardiovascular Disease Prevention Using Fixed Dose Pharmacotherapy in Iran: Updated Meta-Analyses and Mortality Estimation
448
Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis
449
Cardiovascular Disease Risk Assessment: Triglyceride/High-Density Lipoprotein versus Metabolic Syndrome Criteria
450
Cardiovascular Disease Risk Factor Intervention in Low-Income Women: The North Carolina WISEWOMAN Project
451
Cardiovascular Disease Risk Factors
452
Cardiovascular Disease Risk Factors among Migrant Seasonal Agricultural Workers: Comparison with Local Residents
453
Cardiovascular Disease Risk Factors and Cardiac Markers among Male Cement Workers in Calabar, Nigeria
454
Cardiovascular Disease Risk Factors and Cognitive Impairment
455
Cardiovascular disease risk factors in 2 distinct ethnic groups: Indian and Pakistani compared with American premenopausal women
456
Cardiovascular disease risk factors in 6–7-year-old Danish children: the Copenhagen School Child Intervention Study
457
Cardiovascular Disease risk Factors in Male Cigarette Smokers in Calabar, Southern Nigeria
458
Cardiovascular Disease Risk Factors in Patients with Confirmed Cardiovascular Disease
459
Cardiovascular Disease Risk Factors Profile in Individuals With Diabetes Compared With Non-Diabetic Subjects in North-East of Iran
460
Cardiovascular disease risk factors, metabolic syndrome and obesity in an Iranian population
461
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
462
Cardiovascular disease risk prediction among Iranian patients with diabetes mellitus in Isfahan Province, Iran, in 2014, by using Framingham risk score, atherosclerotic cardiovascular disease risk score, and high-sensitive C-reactive protein
463
Cardiovascular disease risk profile among young Saudi women of Al-Qassim, Saudi Arabia: A cross-sectional study
464
Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System Original Research Article
465
Cardiovascular Disease Risk Stratification With Stress Single-Photon Emission Computed Tomography Technetium-99m Tetrofosmin Imaging in Patients With the Metabolic Syndrome and Diabetes Mellitus
466
Cardiovascular disease risks in adolescent males
467
Cardiovascular disease, chronopharmacotherapy, and the molecular clock
468
Cardiovascular disease, fibrinogen and the acute phase response: Associations with lipids and blood pressure in patients with chronic renal disease Original Research Article
469
Cardiovascular disease—risk benefits of clean fuel technology and policy: A statistical analysis
470
Cardiovascular diseases (CVD) risk factors, physical activity (PA) and plasma plasminogen (Plg) in a random sample of community-dwelling elderly
471
Cardiovascular Diseases and Risk Factors in Finland
472
Cardiovascular Diseases before and after Renal Transplantation
473
Cardiovascular diseases do not influence the mental health outcome of older men with depression over 6 years
474
Cardiovascular diseases in Latin America and the Caribbean
475
Cardiovascular Diseases in Natural Disasters; a Systematic Review
476
Cardiovascular diseases in the mirror of science
477
Cardiovascular diseases, health status, brain imaging findings and neuropsychological functioning in neurologically healthy elderly individuals
478
Cardiovascular Disorders in the Context of Non-Alcoholic Fatty Liver Disease: A Literature Review
479
Cardiovascular Disorders Risk Factors in Different Industries of Iran
480
Cardiovascular distribution of the calcium sensing receptor before and after burns
481
Cardiovascular Disturbances in Workers Exposed to Carbon Disulfide
482
Cardiovascular drug delivery with ultrasound and microbubbles
483
Cardiovascular Drug Interactions of Diclofenac and Dobutamine
484
Cardiovascular Dual Source Computed Tomography for Aortic Coarctation in a Neonate: One-Second Scan With Ultra-Low Radiation Dose
485
Cardiovascular dynamics and dimensions after bicaval and standard cardiac transplantation
486
Cardiovascular dysautonomia in Parkinsonʹs disease with visual hallucinations
487
Cardiovascular Effect of Bans on Smoking in Public Places
488
Cardiovascular Effect of Bans on Smoking in Public Places: A Systematic Review and Meta-Analysis
489
Cardiovascular Effect of Cuneiform Nucleus During Hemorrhagic Hypotension
490
Cardiovascular Effect of Dorsal Periaqueductal Gray During Lipopolysaccharide-induced Hypotension
491
Cardiovascular effect of preeclampsia upon offspring development: Are (Pro) renin-renin receptor ((P)RR) and gender related?
492
Cardiovascular effects of 6 months of hormone replacement therapy versus placebo: differences associated with years since menopause
493
Cardiovascular Effects of a Trandolapril/Verapamil Combination in Patients With Mild to Moderate Essential Hypertension
494
Cardiovascular effects of a μ-selective opioid agonist (tyrosine-D-arginine-phenylalanine-lysine-NH2) in fetal sheep: Sites and mechanisms of action, ,
495
Cardiovascular Effects of Acute Organophosphate Poisoning
496
Cardiovascular effects of Adonis aestivalis in anesthetized sheep
497
Cardiovascular Effects of Aldosterone and Post–Acute Myocardial Infarction Pathophysiology
498
Cardiovascular Effects of Allium Sativum (Garlic): An Evidence-Based Review
499
Cardiovascular Effects of Androgenic Anabolic Steroids in Male Bodybuilders Determined by Tissue Doppler Imaging
500
Cardiovascular Effects of Antidepressants and Mood Stabilizers
501
Cardiovascular effects of breast cancer radiotherapy
502
Cardiovascular effects of caffeine in men and women
503
Cardiovascular Effects of Carbamazepine Toxicity, ,
504
Cardiovascular effects of carbon monoxide and cigarette smoking
505
Cardiovascular Effects of Carbon Monoxide Poisoning
506
Cardiovascular effects of centrally applied endothelin-11–31 and its relationship to endothelin-11–21 in rats
507
Cardiovascular Effects of Circular Training (Resistance-Interval) Combined with Berberine on Overweight Elderly Men
508
Cardiovascular effects of Danshen
509
Cardiovascular effects of estrogen
510
Cardiovascular Effects of Exercise: Role of Endothelial Shear Stress
511
Cardiovascular effects of fingolimod: A review article.
512
Cardiovascular effects of French horn playing
513
Cardiovascular Effects of Hyperhomocysteinemia in Conscious Unrestrained Rats
514
Cardiovascular effects of induced hypothermia after lung transplantation
515
Cardiovascular effects of inhaled nitric oxide in a canine model of cardiomyopathy
516
Cardiovascular effects of inhaled nitric oxide in a canine model of cardiomyopathy
517
Cardiovascular effects of intravaginal misoprostol in the mid trimester of pregnancy
518
Cardiovascular effects of milk enriched with ω-3 polyunsaturated fatty acids, oleic acid, folic acid, and vitamins E and B6 in volunteers with mild hyperlipidemia
519
Cardiovascular Effects of Mixed Amphetamine Salts Extended Release in the Treatment of School-Aged Children with Attention-Deficit/Hyperactivity Disorder
520
Cardiovascular effects of nitrergic system of the pedunculopon-tine tegmental nucleus in anesthetized rats
521
Cardiovascular Effects of Olive, a Qur’anic Fruit: a Systematic Review
522
Cardiovascular effects of prolonged milrinone inhalation inpatients with pulmonary hypertension undergoing mitral valvereplacement
523
Cardiovascular effects of propranolol in normal and stressed female and male rats assessed by traditional and nonlinear dynamics methods
524
Cardiovascular effects of raloxifene: the arterial and venous systems
525
Cardiovascular Effects of Saffron: An Evidence-Based Review
526
Cardiovascular effects of sex hormones
527
Cardiovascular effects of sildenafil citrate and recommendations for its use
528
Cardiovascular effects of standardized hydroalcoholic extract of Ribes khorasanicum fruit in acute hypertensive rats
529
Cardiovascular effects of systemic cancer treatment
530
Cardiovascular effects of tadalafil
531
Cardiovascular effects of tadalafil in patients on common antihypertensive therapies
532
Cardiovascular effects of transdermal nicotine in mildly hypertensive smokers
533
Cardiovascular effects of two amides (Piperine and Piperdardine) isolated from Piper tuberculatum Jacq.
534
Cardiovascular Emergencies in Cruise Ship Passengers
535
Cardiovascular endocrinology springs surprises
536
Cardiovascular Event Rates in Diabetic and Nondiabetic Individuals With and Without Established Atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)
537
Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol <50 mg/dl With Rosuvastatin: The JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvast
538
Cardiovascular event risk in relation to arterial stiffness in patients with subclinical peripheral atherosclerosis
539
Cardiovascular Event Risk: High-Density Lipoprotein and Paraoxonase
540
Cardiovascular Events and Football Tournaments
541
Cardiovascular Events and Mortality in Newly and Chronically Depressed Persons >70 Years of Age
542
Cardiovascular events and plasma atrial natriuretic peptide level in patients with hypertrophic cardiomyopathy
543
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial
544
Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes
545
Cardiovascular events during initial antihypertensive therapy with either a calcium antagonist or a diuretic/beta-blocker: meta-analysis of 7 clinical trials
546
Cardiovascular Events in Patients With Coronary Plaque Rupture and Nonsignificant Stenosis
547
Cardiovascular Events in Patients With Fabry Disease: Natural History Data From the Fabry Registry
548
Cardiovascular Events in People With Type 2 Diabetes: Performance of Framingham, UKPDS, and ADVANCE Risk Equations
549
Cardiovascular Events in the 1996 Olympic Games
550
Cardiovascular Factors and Cognitive Impairment: A Role for Unsaturated Fatty Acids and Mediterranean Diet?
551
Cardiovascular Features of Heart Failure With Preserved Ejection Fraction Versus Nonfailing Hypertensive Left Ventricular Hypertrophy in the Urban Baltimore Community: The Role of Atrial Remodeling/Dysfunction Original Research Article
552
Cardiovascular findings in patients with psoriasis.
553
Cardiovascular fitness and neurocognitive function in older Adults: a brief review
554
Cardiovascular Function and Predictors of Exercise Capacity in Patients With Colorectal Cancer
555
Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice
556
Cardiovascular gene delivery: The good road is awaiting
557
Cardiovascular gene therapy Review Article
558
Cardiovascular Gene Therapy: Advances and Challenges
559
Cardiovascular Genetics, Genomics, and Proteomics
560
Cardiovascular genomics
561
Cardiovascular Genomics: Estimating the Total Number of Genes Expressed in the Human Cardiovascular System
562
Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study
563
Cardiovascular Health among Adults in Syria: A Model from Developing Countries
564
Cardiovascular health and economic effects of smoke-free workplaces
565
Cardiovascular health and economic effects of smoke-free workplaces: Am J Med. 2004;117:32-38
566
Cardiovascular Health Awareness Program (CHAP): A community cluster-randomised trial among elderly Canadians
567
CARDIOVASCULAR HEALTH EDUCATION OF FAMILIES: THE IMPORTANCE OF SCHOOL-BASED PREVENTION STRATEGIES
568
Cardiovascular Health in Europe: A Global Problem
569
Cardiovascular Health in Men Attending for Abdominal Aortic Aneurysm Screening
570
Cardiovascular hybrid drugs: new benzazepinone derivatives as bradycardic agents endowed with selective β1-Non-competitive antagonism Original Research Article
571
Cardiovascular imaging
572
Cardiovascular Imaging in Thalassemia: An Issue With Limited Data
573
Cardiovascular Imaging in the Management of Atrial Fibrillation Review Article
574
Cardiovascular implications of the factor V Leiden mutation
575
Cardiovascular Interventions in Clinical Practice
576
Cardiovascular Inventiveness Within the University of Minnesota Department of Surgery
577
cardiovascular involvement in blood cancers: all, aml, cll, and cml
578
Cardiovascular Involvement in Children with Osteogenesis Imperfecta
579
Cardiovascular involvement in patients with systemic sclerosis: insights from electromechanical characteristics of the heart
580
Cardiovascular involvement in systemic autoimmune diseases
581
Cardiovascular Issues in Hypogonadism and Testosterone Therapy
582
Cardiovascular Magnetic Resonance Determinants of Left Ventricular Noncompaction
583
Cardiovascular magnetic resonance findings in typical versus atypical forms of the acute apical ballooning syndrome (Takotsubo cardiomyopathy)
584
Cardiovascular Magnetic Resonance for Risk Stratification of Arrhythmia in Hypertrophic Cardiomyopathy
585
Cardiovascular magnetic resonance for the assessment of pulmonary arterial hypertension: toward a comprehensive CMR exam
586
Cardiovascular Magnetic Resonance for the Diagnosis of Acute Myocarditis: Prospects for Detecting Myocardial Inflammation
587
Cardiovascular magnetic resonance imaging demonstrates mitral valve endocarditis
588
Cardiovascular magnetic resonance imaging: Current and emerging applications Review Article
589
Cardiovascular Magnetic Resonance in Arrhythmogenic Right Ventricular Cardiomyopathy Revisited: Comparison With Task Force Criteria and Genotype Original Research Article
590
Cardiovascular Magnetic Resonance in Clinically Suspected Cardiac Amyloidosis: Diagnostic Value of a Typical Pattern of Late Gadolinium Enhancement
591
Cardiovascular Magnetic Resonance in Clinically Suspected Cardiac Amyloidosis: Noninvasive Imaging Compared to Endomyocardial Biopsy Original Research Article
592
Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
593
Cardiovascular Magnetic Resonance in Patients With Myocardial Infarction: Current and Emerging Applications
594
Cardiovascular Magnetic Resonance in Predicting the Reduction in Pulmonary Artery Pressure in Patients With Mitral Stenosis After Surgical or Interventional Treatment
595
Cardiovascular magnetic resonance in the follow-up of patients with corrected tetralogy of Fallot: A review
596
Cardiovascular magnetic resonance of asymptomatic myocardial infarction
597
Cardiovascular magnetic resonance of iatrogenic ventricular scarring due to catheter ablation for left ventricular tachycardia
598
Cardiovascular Magnetic Resonance of imminent cardiac tamponade due to postpericardiotomy syndrome
599
Cardiovascular magnetic resonance ofacute myocardial infarction at a very early stage
600
Cardiovascular Magnetic Resonance Perfusion Imaging at 3-Tesla for the Detection of Coronary Artery Disease: A Comparison With 1.5-Tesla Original Research Article
601
Cardiovascular magnetic resonance signs of ischemia in hypertrophic cardiomyopathy
602
Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy Original Research Article
603
Cardiovascular Magnetic Resonance: Warren J. Manning and Dudley J. Pennell, London, UK, Churchill Livingstone 2002, 506 pages, 367 illustrations, US$120.00
604
Cardiovascular Malformations in Congenital Rubella Syndrome: A Case Report
605
Cardiovascular malformations in Fryns Syndrome
606
Cardiovascular Malformations in Infants of Diabetic Mothers: A Retrospective Case-Control Study
607
Cardiovascular Manifestation of a Family with Marfan’s Syndrome
608
Cardiovascular manifestations associated with influenza virus infection
609
Cardiovascular manifestations in COVID-19 patients: A systematic review and meta-analysis
610
Cardiovascular Manifestations in Human Immunodeficiency Virus-Infected Patients
611
Cardiovascular manifestations of anabolic steroids in association with demographic variables in body building athletes
612
Cardiovascular Manifestations of Carbon Monoxide Poisoning
613
Cardiovascular Manifestations of Hyperthyroidism Before and After Antithyroid Therapy: A Matched Case-Control Study Original Research Article
614
Cardiovascular Manifestations of Moderate to Severe Carbon Monoxide Poisoning Original Research Article
615
Cardiovascular manifestations of pheochromocytoma
616
Cardiovascular Medications and Risk of Cancer
617
Cardiovascular medicine update
618
Cardiovascular monitoring advised during growth hormone therapy
619
Cardiovascular Morbidity and Mortality in Community-Dwelling Elderly Individuals With Calcification of the Fibrous Skeleton of the Base of the Heart and Aortosclerosis (The Cardiovascular Health Study)
620
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End point reduction in hypertension (LIFE) study Original Research Article
621
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
622
Cardiovascular Morbidity and Mortality in Rheumatoid Arthritis
623
Cardiovascular Morbidity and Mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in Chronic Renal Failure: A Multicenter, Randomized, Controlled Trial Original Research Article
624
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
625
Cardiovascular Morphing
626
Cardiovascular Mortality and Heart Failure Risk Score for Patients After ST-Segment Elevation Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (Data from the Leiden MISSION! Infarct Registry)
627
Cardiovascular mortality focusing on socio-economic influence: The low-risk population of Halland compared to the population of Sweden as a whole
628
Cardiovascular Mortality in Chronic Kidney Disease Patients Undergoing Percutaneous Coronary Intervention Is Mainly Related to Impaired P2Y12 Inhibition by Clopidogrel
629
Cardiovascular Mortality in High-Risk Patients and T-786C Polymorphism in Promoter Region of the Endothelial Nitric Oxide Synthase Gene
630
Cardiovascular mortality in New York City after September 11, 2001
631
Cardiovascular mortality in patients followed up for diabetic foot
632
Cardiovascular Mortality of Turkish Nationals Residing in West Germany
633
Cardiovascular neurons of the rat brain express extracellular calcium-sensing receptors
634
Cardiovascular operations in patients with dialysis-dependent renal failure
635
Cardiovascular outcome in hospitalized patients with minimal troponin I elevation and normal creatine phosphokinase
636
Cardiovascular Outcome in Relation to Progression to Hypertension in the Copenhagen MONICA Cohort
637
Cardiovascular Outcome in Treated Hypertensive Patients with Responder, Masked, False Resistant, and True Resistant Hypertension
638
Cardiovascular outcome of patients with abnormal coronary vasomotion and normal coronary arteriography is worse in type 2 diabetes mellitus than in arterial hypertension: A 10 year follow-up study
639
Cardiovascular Outcomes in Male Veterans With Rheumatoid Arthritis
640
Cardiovascular Outcomes in Randomized Trials: Should Time to First Event for “Hard” End Points Remain the Standard Approach?
641
Cardiovascular Outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management): An Assessment of Individual Antiarrhythmic Drug Therapies Compared With Rate Control With Propensity Score-Matched Analyses
642
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison
643
Cardiovascular Pathology A platform for research, teaching, and clinical care
644
Cardiovascular pathology at the crossroads: the dilemma of cardiac pathologists
645
Cardiovascular pathology in the land of doges
646
Cardiovascular Pathology: a new journal for an old need
647
Cardiovascular pathology: Clinicopathological correlations and pathogenetic mechanisms : Schoen FJ, Gimbrone MA (editors) Williams and Wilkins, Georgia, USA; 229 pp.; £67.00; ISBN 0-683-07600-0
648
Cardiovascular Pathology: From whence we came … to where we are going
649
Cardiovascular pathology: maturation of a discipline and the Society for Cardiovascular Pathology
650
Cardiovascular patients’ experiences of living with pacemaker: Qualitative study
651
Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerations
652
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction
653
Cardiovascular Phenotype in HFpEF Patients With or Without Diabetes: A RELAX Trial Ancillary Study
654
Cardiovascular Preventing Effects of Dipeptidyl Peptidase-4 Inhibitors: Beyond Glucagon-Like Peptide-1
655
Cardiovascular Prevention in Asymptomatic Diabetic Patients
656
Cardiovascular Prevention in Diabetes Mellitus: No Magic Remedies
657
Cardiovascular prevention in the Hartslag Limburg project: Effects of a high-risk approach on behavioral risk factors in a general practice population
658
Cardiovascular professionalism and ethics in the modern era Review Article
659
Cardiovascular profile of loratadine
660
Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: Results from the Angina Prognosis Study in Stockholm (APSIS) Original Research Article
661
Cardiovascular prognostic value of vascular involvement in Behcetʹs disease
662
Cardiovascular Property of Resistance Training With an Emphasis on PI3K/AKT1 Genes Expression in Type 2 Diabetic Rats
663
Cardiovascular protection and blood pressure reduction: a meta-analysis
664
Cardiovascular protection in haemophilia
665
Cardiovascular protection of deep-seawater drinking water in high-fat/cholesterol fed hamsters
666
Cardiovascular protection of nonmitogenic human acidic fibroblast growth factor from oxidative damage in vitro and in vivo
667
Cardiovascular Protection Using Beta-Blockers: A Critical Review of the Evidence Review Article
668
Cardiovascular protective effect of darbepoetin-α: A long-acting erythropoietic analogue
669
Cardiovascular proteomic analysis
670
Cardiovascular Proteomics: Tools to Develop Novel Biomarkers and Potential Applications Review Article
671
Cardiovascular reactivity and hostility: The dynamic cerebral laterality effect
672
Cardiovascular reactivity, affective responses and performance related to the risk dimensions of coronary-prone behaviour
673
Cardiovascular recovery from laboratory stress: Biopsychosocial concomitants in older adults
674
Cardiovascular regulation by -atginine in the brain of rats : Role of the brain renin-angiotensin system and nitric oxide
675
CARDIOVASCULAR REGULATION IN TGR(mREN2)27 RATS: 24h VARIATION IN PLASMA CATECHOLAMINES, ANGIOTENSIN PEPTIDES, AND TELEMETRIC HEART RATE VARIABILITY
676
Cardiovascular remodeling after AVF surgery in rats assessed by a clinical MRI scanner
677
Cardiovascular remodeling and arterial hypertension in rheumatoid arthritis: Predisposing conditions and risk factors  
678
Cardiovascular remodeling is greater in isolated systolic hypertension than in diastolic hypertension in older adults: the Insufficienza Cardiaca negli Anziani Residenti (ICARE) a Dicomano Study
679
Cardiovascular remodeling, apoptosis, and drugs
680
Cardiovascular research in Spain. A comparative scientometric study
681
Cardiovascular response to sexual activity
682
Cardiovascular responses across stressor phases: The match of gender and gender-role identification with the gender relevance of the stressor
683
Cardiovascular Responses during Head-Down Crooked Kneeling Position Assumed in Muslim Prayers
684
Cardiovascular responses evoked by mild cool stimuli in primary Raynauds disease: the role of endothelin
685
Cardiovascular responses in humans to experimental chewing of gums of different consistencies
686
Cardiovascular responses in patients with acute allergic reactions treated with parenteral epinephrine
687
Cardiovascular responses induced by Catalase Inhibitior into the Fourth Cerebral Ventricle is changed in Wistar rats exposed to sidestream cigarette smoke
688
Cardiovascular responses of perimenopausal women to hormonal replacement therapy, ,
689
Cardiovascular responses of physically active colligate subjects during normal and warm conditions, and determination of sweat rates
690
Cardiovascular responses produced by resistin injected into paraventricular nucleus mediated by the glutamatergic and CRFergic transmissions within rostral ventrolateral medulla
691
Cardiovascular responses to agency and communion stressors in young women
692
Cardiovascular responses to aquatic walking in middle-aged and elderly persons with physical disabilities
693
Cardiovascular responses to chemoreflex activation with potassium cyanide or hypoxic hypoxia in awake rats
694
Cardiovascular responses to clonidine in alcohol withdrawal: are they related to psychopathology and mental well-being?
695
Cardiovascular responses to dynamic submaximal exercise in children previously treated with anthracycline
696
Cardiovascular responses to electrical stimulation of sympathetic nerves in the pithed mouse
697
Cardiovascular responses to exercise in children and adolescents with myocardial dysfunction
698
Cardiovascular responses to laughter: A pilot project
699
Cardiovascular responses to microinjection of AMPA into the rostral commissural nucleus tractus solitarius of awake rats
700
CARDIOVASCULAR RESPONSES TO OROTRACHEAL INTUBATION IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING SURGERY (Comparing Fiberoptic Bronchoscopy With Direct Laryngoscopy)
701
CARDIOVASCULAR RESPONSES TO SCALP INFILTRATION, USING ADRENALINE, WITH OR WITHOUT LIGNOCAINE, DURING CRANIOTOMY
702
Cardiovascular responses to sciatic nerve stimulation are blocked by paratrigeminal nucleus lesion
703
Cardiovascular responses to the injection of L-glutamate in the lateral hypothalamus of unanesthetized or anesthetized rats
704
Cardiovascular Responses to Tonic Pain in REM Sleep-Deprived Rats Role of Melatonin and Beta Endorphin
705
Cardiovascular Risk After Bariatric Surgery for Obesity
706
Cardiovascular Risk Among Adults With Chronic Kidney Disease, With or Without Prior Myocardial Infarction Original Research Article
707
Cardiovascular Risk Among Men Seeking Help for Erectile Dysfunction
708
Cardiovascular risk and atherosclerosis prevention
709
Cardiovascular risk and blood pressure reduction: an overview of the outcome trials
710
Cardiovascular risk and sildenafil
711
Cardiovascular risk assessment
712
Cardiovascular risk assessment
713
Cardiovascular risk assessment in HIV-infected patients attending a designated lipid clinic
714
Cardiovascular Risk Assessment of Liver Transplantation Candidates
715
Cardiovascular Risk Assessment of Pulmonary Embolism With the GRACE Risk Score
716
Cardiovascular Risk Assessment of the Liver Transplant Candidate
717
Cardiovascular risk associated with hormone replacement therapy: some critical questions about the type of estrogen used in most clinical trials
718
Cardiovascular risk changes after lipid lowering medications: are they predictable?
719
Cardiovascular risk continuum: implications of insulin resistance and diabetes
720
Cardiovascular Risk Estimation and Eligibility for Statins in Primary Prevention Comparing Different Strategies
721
Cardiovascular Risk Factor Control and Adherence to Recommended Lifestyle and Medical Therapies in Persons With Coronary Heart Disease (from the National Health and Nutrition Examination Survey 2007–2010)
722
Cardiovascular risk factor profiles and their social gradient from adolescence to age 74 in a Swiss region
723
Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial
724
Cardiovascular Risk Factors among Children after a 2image-Year Intervention—The CATCH Study
725
Cardiovascular risk factors among retired attendees visiting primary care clinics
726
Cardiovascular Risk Factors and Acculturation in Yaquis and Tepehuanos Indians from Mexico
727
Cardiovascular risk factors and alcohol consumption in France and Northern Ireland Original Research Article
728
Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults
729
Cardiovascular Risk Factors and Confounders Among Nondrinking and Moderate-Drinking U.S. Adults
730
Cardiovascular Risk Factors and Coronary Atherosclerosis in Retired National Football League Players
731
Cardiovascular Risk Factors and COVID-19 incidence- Result from a population based study
732
Cardiovascular risk factors and hyperinsulinemia in elderly men: The Honolulu Heart Program
733
CARDIOVASCULAR RISK FACTORS an‎d IN-HOSPITAL MORTALITY IN 1258 CASES OF CORONARY ARTERY BYPASS SURGERY IN TEHRAN HEART CENTER
734
Cardiovascular risk factors and migraine without aura: A case-control study.
735
Cardiovascular Risk Factors and Nutritional Intake are not Associated with Ultrasound-defi ned Increased Carotid Intima Media Thickness in Individuals Without a History of Cardiovascular Events
736
Cardiovascular Risk Factors and Specific Coronary Artery Calcification in Postmenopausal Women
737
Cardiovascular Risk Factors Are on the Rise in Developing Countries
738
Cardiovascular risk factors are really linked in the metabolic syndrome: This phenomenon suggests clustering rather than coincidence
739
Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population
740
Cardiovascular risk factors associated with enlarged diameter of the abdominal aortic and iliac arteries in healthy women
741
Cardiovascular risk factors associated with migraine
742
Cardiovascular Risk Factors Clustering Features of Insulin Resistance Syndrome (Syndrome X) in a Biracial (Black-White) Population of Children, Adolescents, and Young Adults The Bogalusa Heart Study
743
Cardiovascular Risk Factors Clustering Features of Insulin Resistance Syndrome (Syndrome X) in a Biracial (Black-White) Population of Children, Adolescents, and Young Adults The Bogalusa Heart Study
744
Cardiovascular Risk Factors Determine Erectile and Arterial Function Response to Sildenafil
745
Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction
746
Cardiovascular Risk Factors in Adolescence: Prevalence and Familial Aggregation
747
Cardiovascular risk factors in ethnic minority women aged ≤30 years
748
Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients
749
Cardiovascular Risk Factors in Hypertension: Rationale and Design of Studies to Investigate the Effects of Controlled-Release Carvedilol on Regression of Left Ventricular Hypertrophy and Lipid Profile
750
Cardiovascular Risk Factors in Italy
751
Cardiovascular risk factors in Kuwaiti adults with type 2 diabetes
752
Cardiovascular risk factors in Montana American Indians with and without diabetes Original Research Article
753
Cardiovascular risk factors in non-insulin-dependent diabetics compared to non-diabetic controls: a population-based survey among Asians in Singapore Original Research Article
754
Cardiovascular risk factors in patients aged 85 or older with ischemic stroke
755
Cardiovascular risk factors in people abovetwenty years old in Gonabad, Iran
756
Cardiovascular risk factors in relation to cigarette smoking: a population-based survey among Asians in Singapore Original Research Article
757
Cardiovascular risk factors in Tanzania: a revisit
758
Cardiovascular risk factors in the urban Mexican population: The FRIMEX study
759
Cardiovascular Risk Factors in Young Patients of Coronary Artery Disease: Differences over a Decade
760
Cardiovascular risk factors in youth with implications for aging: The Bogalusa Heart Study
761
Cardiovascular risk factors of hypertension, smoking and obesity: Emerging concerns among Pathan and Persian young adults?
762
Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension
763
Cardiovascular Risk Factors: A Study on the Prevalence of MS among 11-18 Years Old School Children in East of Iran, 2012
764
Cardiovascular risk in a hypertension clinic-implications of the Sheffield Table for lipid-lowering strategy
765
Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration: A Systematic Meta-Analysis
766
Cardiovascular risk in long-term survivors of testicular cancer: Vaughn DJ, Palmer SC, Carver JR, Jacobs LA, Mohler ER, Department of Medicine, Hematology/Oncology Division, University of Pennsylvania, Philadelphia, PA; Department of Psychiatry, Universit
767
Cardiovascular Risk in Men Aged Over 40 in Boa Vista, Brazil
768
Cardiovascular risk in patients with bipolar disorder
769
Cardiovascular Risk in Patients With Fasting Blood Glucose Levels Within Normal Range
770
Cardiovascular Risk in Patients With Human Immunodeficiency Virus Infection: Incomplete Data
771
Cardiovascular risk in patients with plaque psoriasis and psoriatic arthritis without a clinically overt cardiovascular disease: the role of endothelial progenitor cells
772
Cardiovascular risk in rheumatoid arthritis
773
Cardiovascular Risk in Survivors of Stroke Original Research Article
774
Cardiovascular Risk in Women With Non-Specific Chest Pain (from the Womenʹs Health Initiative Hormone Trials)
775
Cardiovascular Risk in Women With PCOS
776
Cardiovascular risk management in clinical practice: the midwest heart specialists experience
777
Cardiovascular risk models; is there an ideal model?
778
Cardiovascular risk of antidepressant use in elderly medicare beneficiaries: Comparison by therapeutic class
779
Cardiovascular Risk Perception among Iranian Women with type 2 Diabetes Mellitus
780
Cardiovascular Risk Profile and Lifestyle Habits in a Cohort of Italian Cardiologists (from the SOCRATES Survey)
781
Cardiovascular Risk Profile of Apparently Healthy Workers in a Tertiary Hospital in Nigeria
782
Cardiovascular risk profiles in UK-born Caribbeans and Irish living in England and Wales
783
Cardiovascular Risk Profiles of Oral Contraceptive Users and Nonusers: A Population-Based Study
784
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: The life study Original Research Article
785
Cardiovascular risk reductions associated with aggressive lifestyle modification and cardiac rehabilitation
786
Cardiovascular risk score in Rheumatoid Arthritis
787
Cardiovascular risk stratification by means of the SCORE system in health care workers in Veracruz, Mexico
788
Cardiovascular risk stratification of pulmonary embolism
789
Cardiovascular Risk Stratification With Plasma B-Type Natriuretic Peptide Levels in a Community-Based Hypertensive Cohort
790
Cardiovascular Risk-Factors in the Eastern Iranian Population: Are We Approaching 25×25 Target?
791
Cardiovascular risk-factors predict progression of urinary albumin-excretion in a general, non-diabetic population: A gender-specific follow-up study
792
CARDIOVASCULAR RISKS AMONG SHIFT AND NON-SHIFT WORKERS IN A PUBLIC MEDICAL CENTRE IN KUALA LUMPUR
793
Cardiovascular safety of cyclo-oxygenase-2 inhibitors
794
Cardiovascular safety of cyclo-oxygenase-2 inhibitors – Authorsʹ reply
795
Cardiovascular safety of fexofenadine HCI
796
Cardiovascular Safety of Fexofenadine HCl
797
Cardiovascular safety of maximal strength testing in healthy adults
798
Cardiovascular safety of rosiglitazone
799
Cardiovascular safety of sublingual apomorphine in patients on stable doses of oral antihypertensive agents and nitrates
800
Cardiovascular Safety Update of Tadalafil: Retrospective Analysis of Data from Placebo-Controlled and Open-Label Clinical Trials of Tadalafil With As Needed, Three Times-per-Week or Once-a-Day Dosing
801
Cardiovascular Screening and Emergency Procedures at Health Clubs and Fitness Centers
802
Cardiovascular sequelae of childhood hypertension
803
Cardiovascular solid mechanics. Cells, tissues, and organs: Jay D. Humphrey (Ed.); Springer verlag, New York, 2002, pp. 776, price US$99.00 hardback, ISBN 0-387-95168-7
804
Cardiovascular status of infants and children of women infected with HIV-1 (P2C2 HIV): a cohort study
805
Cardiovascular stent design and vessel stresses: a finite element analysis
806
Cardiovascular stents: overview, evolution, and next generation
807
Cardiovascular stress response and coronary artery disease: Evidence of an adverse postmenopausal effect in women, , , ,
808
Cardiovascular surgeonʹs remarks cause uproar in Spain
809
Cardiovascular system and intermittent stress: Bloodless adaptation to blood loss
810
Cardiovascular system is at higher risk of affecting by COVID-19
811
Cardiovascular targets for estrogens and phytoestrogens: Transcriptional regulation of nitric oxide synthase and antioxidant defense genes
812
Cardiovascular Therapies and Risk for Development of Diabetes Review Article
813
Cardiovascular therapy of neurosurgical patients
814
Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib
815
Cardiovascular tissue engineering
816
Cardiovascular Tissue Engineering Therapy: So Near, So Far?
817
Cardiovascular Toxicity of Nicotine: Implications for Nicotine Replacement Therapy
818
Cardiovascular Ultrasonographic Features and Clinical Findings for Intravenous Leiomyomatosis: A Case Report
819
Cardiovascular variability characteristics in obstructive sleep apnea
820
Cardiovascular variability during periodic leg movements: a spectral analysis approach
821
Cardiovascular, Antinociceptive and Sedative Effects of Medetomidine Infusion in Sevoflurane Anesthesia in Puppies
822
Cardiovascular, Haematological and Biochemical Responses After Large Volume Blood Collection in Horses
823
Cardiovascular, neuroendocrine, and monoaminergic responses to psychological stressors: Possible differences between remitted panic disorder patients and healthy controls
824
Cardiovascular, respiratory, and panic reactions to epinephrine in panic disorder patients
825
Cardiovascular-radical outcome method is effective in complex congenital cardiac lesions
826
Cardiovascular-Renal Responses to Long-Term Nitric Oxide Inhibition During Angiotensin II-AT1 Receptor Inhibition
827
Cardioversion for Atrial Fibrillation: Does Inflammation Matter?
828
Cardioversion of atrial fibrillation and its effect on right ventricular function as assessed by tricuspid annular motion
829
Cardioversion of atrial fibrillation in the elderly
830
Cardioversion of atrial fibrillation in the setting of mild to moderate heart failure
831
Cardioversion of atrial fibrillation to sinus rhythm: who, when, how, and why?
832
Cardioversion of Paroxysmal Atrial Fibrillation in the Emergency Department, ,
833
Cardioversion under the guidance of transesophageal echochardiograhy in persistent atrial fibrillation: results with low molecular weight heparin
834
Cardioversion With Novel Oral Anticoagulants: Reconfirming a 50-Year-Old Standard
835
Cardioverter defibrillator implantation in an adult with isolated noncompaction of the ventricular myocardium
836
Cardioverter-defibrillator implantation in the catheterization laboratory: Initial experiences in 48 patients
837
Cardioverter-defibrillator oversensing due to double counting of ventricular tachycardia electrograms
838
CardioVision 2020: Program Acceptance and Progress After 4 Years Original Research Article
839
Cardiovocal syndrome after transradial cardiac catheterization: An unusual complication
840
CardioWest Total Artificial Heart in a Moribund Adolescent With Left Ventricular Thrombi
841
CardioWest Total Artificial Heart: Bad Oeynhausen Experience
842
Cardiprotective effects of chronic hypoxia and preconditioning are not additive. Role of mitochondrial KATP channels
843
Cardo poly(arylene ether sulfone) block copolymers with pendant imidazolium side chains as novel anion exchange membranes for direct methanol alkaline fuel cell
844
Cardosin A as a model aspartic proteinase for the study of organic solvent effects: An overview on catalytic and structural aspects
845
Cardre to be absorbed into LCW after acquisition by Sensient Technologies
846
Cardré’s black iron oxide for eye make-up
847
Cardy states, factorization and idempotency in closed string field theory Original Research Article
848
Cardy–Verlinde formula and asymptotically de Sitter spaces
849
Cardy–Verlinde formula and thermodynamics of black holes in de Sitter spaces Original Research Article
850
Care after cure in leprosy
851
Care and cure. An integrated approach to psychosomatic medicine: A report from the second annual conference the EAPM, Sibiu, 2014
852
Care and despair in the UK National Health Service
853
Care and Do Not Harm: Possible Misunderstandings With Quaternary Prevention (P4); Comment on “Quaternary Prevention, an Answer of Family Doctors to Over Medicalization”
854
Care and feeding of reproducible econometrics
855
Care and NonCare‑Related Activities among Critical Care Nurses: A Cross‑Sectional Observational Time and Motion Study
856
Care and outcomes of elderly patients with acute myocardial infarction by physician specialty: the effects of comorbidity and functional limitations
857
Care and Support for Adolescents Living with HIV/AIDS in School Settings: Perspectives of Teachers and Administrators in the Southern Highlands of Tanzania
858
Care and Use of Diamond Knives
859
Care at first-level facilities for children with severe pneumonia in Bangladesh: a cohort study
860
Care Burden in Parents of Children with Leukemia: A Cross-Sectional Study in the West of Iran
861
Care concordant with guidelines predicts decreased long-term mortality in patients with unstable angina pectoris and non–ST-Elevation myocardial infarction
862
Care delivery innovation in an integrated health system
863
Care Dependency and Diabetes Self-Care Activities in Elderly Individuals with Diabetes
864
Care disparities: Moving from gray to black and white
865
Care emerges from chaos
866
Care for elderly in USA goes subacute
867
Care for Evidence-Based Applications During Pregnancy
868
Care for stroke patients
869
Care for stroke patients
870
Care for stroke patients
871
Care in comatose surviors of cardiac arrest
872
Care in the community
873
Care Instability in Nursing Homes; A Qualitative Study
874
Care Integration – From “One Size Fits All” to Person Centred Care; Comment on “Achieving Integrated Care for Older People: Shuffling the Deckchairs or Making the System Watertight for the Future?”
875
Care Management Challenges for Diabetic Foot Ulcers: A Qualitative Study
876
Care meanings, expressions, and experiences of those with chronic mental illness
877
Care needs and point prevalence of post-acute patients in the acute medical wards of an Italian hospital
878
Care needs and preferences from the perspective of COVID-19 patients: A qualitative study
879
Care Needs in the Phase I of Cardiac Rehabilitation: A Hybrid Concept Analysis
880
Care Needs of Children with Inborn Errors of Metabolism and Their Parents: An Integrative Review
881
Care Needs of Patients with Cancer; a Systematic Review
882
Care of acute myocardial infarction by nonivasive and invasive cardiologist: Procedure use, cost and outcome
883
Care of burns victims in Europe
884
Care of cardiac surgical patients
885
Care of children who have had surgery for congenital heart disease
886
CARE OF DEMENTIA IN CANADA: A COLLABORATIVE CARE APPROACH WITH A CENTRAL ROLE FOR THE PRIMARY CARE PHYSICIAN
887
Care of Diabetic Retinopathy Patients in Oman
888
Care of handicapped in Gaza
889
Care of learning-disabled Russian children condemned
890
Care of Minor Injuries by Emergence Nurse Practitioners or Junior Doctors: A Randomised Controlled Trial
891
Care of minor injuries by emergency nurse practitioners or junior doctors: a randomised controlled trial Original Research Article
892
Care of non-ST-segment elevation patients: Insights from the crusade national quality improvement initiative
893
Care of older people in nursing homes: an Intensive Programme as an educational activity within Erasmus–Socrates
894
Care of terminally-ill patients: an opinion survey among critical care healthcare providers in the Middle East
895
Care of the adult with congenital heart disease: introduction
896
Care of the Athlete With Type 1 Diabetes Mellitus: A Clinical Review
897
Care of the critically ill parturient: oliguria and renal failure
898
Care of the elderly with gastrointestinal problems in family practice
899
Care of the end-stage renal disease patient on dialysis in the ED
900
Care of the organization: Training and development strategies
901
Care of the pacemaker/implantable cardioverter defibrillator patient in the ED
902
Care of the patient close to death
903
Care of the renal transplant recipient in the emergency department
904
Care of the woman with hypertension in pregnancy: the viewpoint of the midwife
905
Care or control: health or criminal justice options for the long-term seriously mentally ill in a Canadian province
906
Care or scare: The safety of youth in congregate care in New York City
907
Care pathways for south Asian and white people with depressive and anxiety disorders in the community
908
Care pathways in thrombosis management: the INNOVATE peer-to-peer educational initiative
909
Care process and satisfaction analysis of a transmural home care program Original Research Article
910
Care Process in Iranian Nursing Homes: A Grounded Theory Study
911
Care Providers’ Perspectives on Quality Prenatal Care in High-risk Pregnancies: A Qualitative Study
912
Care provision and community adjustment of rural consumers with serious mental illness
913
Care seeking in Sri Lanka: one possible explanation for low childhood mortality
914
Care Seeking Patterns of STIs-Associated Symptoms in Iran: Findings of a Population-Based Survey
915
Care Seeking Practices of Mothers Regarding Four Key Family Practices Related to Child Health and Development
916
Care to be a nurse? Reflections on a radio broadcast and its ramifications for nursing today
917
Care Work Migration in Germany: Semi-Compliance and Complicity
918
CARE: an automobile crash data analysis tool
919
Carebene and isocyanide ligation at ruthenium(II) with (η6-arene) and tethered phosphinopropylarene ligands
920
CAREdose 4D Application in Brain CT Scan: The Effect on Dose and Image Quality
921
Career advancement and scientific performance in universities
922
Career analysis: a case study of hotel general managers in Australia
923
Career anchors and disturbances in job turnover decisions – A case study of IT professionals in Taiwan
924
Career anchors and paths: The case of Gay, Lesbian, & Bisexual workers
925
Career Aspirations And Pregnancy Intentions In Pregnant Teens
926
Career atifaction and urgical practice pattern among female ophthalmologit
927
Career choices for career growth
928
Career choices in health care: Is nursing a special case? A content analysis of survey data
929
Career concerns and mandated disclosure
930
Career concerns in a simple experimental labour market
931
CAREER CONSULTATION AS AN INTERVENTION STRATEGY IN ALLEVIATING FAMILY’S MENTAL HEALTH: A CASE STUDY ON STUDENTS WITH DISABILITIES
932
Career Counseling For Management Students
933
CAREER COUNSELLING FOR CLIENTS WITH PHYSICAL DISABILITIES IN MALAYSIAN CONTEXT
934
Career Decision-Making Self-Efficacy and Its Implications in High School Students during the Covid-19 Pandemic
935
Career decisions: The interim option
936
Career development for infection and immunity research in Uganda: a decade of experience from the Makerere University – Uganda Virus Research Institute research and training programme
937
Career development in organizations and beyond: Balancing traditional and contemporary viewpoints
938
Career development of female managers in retailing: Inhibitors and enablers
939
Career Development of Nursing Preceptors in Iran: A Descriptive Study
940
Career Development of School Psychologists
941
Career Development through E-Learning: The Importance of a Competence-Based Learning Approach
942
Career Dis-integration and Re-integration in Mergers and Acquisitions:: Managing Competence and Motivational Intangibles
943
Career Education in the Primary Grades: Building Work-Readiness Through an Experiential Curriculum
944
Career Guidance Methods for Increasing Career Maturity in Grade IX Students at SMPN 15 Yogyakarta
945
Career guidancefor student nurses: an unmet need
946
Career Indecision and Career Anxiety in High School Students: An Investigation through Structural Equation Modelling
947
CAREER MANAGEMENT COMPETENCY AMONG VOCATIONAL SKILLED MILITARY RETIREES
948
Career management of business expatriates from China
949
Career mothers and perfectionism: stress at work and at home
950
CAREER MOVES: TRANSFER AND RANK CHALLENGE DECISIONS BY MALE LONG-TAILED MACAQUES
951
Career Obstacles of Working Women: A Research in Eskişehir
952
Career options in aerospace and aviation medicine
953
Career orientations and career success among research, and development and engineering professionals
954
Career orientations of information systems employees in South Africa
955
Career paths beyond nursing and the contribution of nursing experience and skills in attaining these positions
956
Career paths for the 21st century. How to beat job insecurity: Jim Duncan and David Oates, Century Business (1996), £12.99
957
Career Paths to Public Health: Programs at the Centers for Disease Control and Prevention Review Article
958
Career Perception at the Republic Indonesian Police Organization Impact of Distributive Fairness, Procedural Fairness and Career Satisfaction on Affective Commitment
959
Career planning and job searching in the information age : edited by Elizabeth A. Lorenzen. Binghampton, NY: Haworth Press, 1996 (simultaneously published as The Reference Librarian, no. 55). 120p. $29.95. ISBN 1-56024-838-6
960
CAREER PLANNING BY THE DOCTORS IN NWFP
961
Career plans and work perceptions of preservice teachers
962
Career plateauing and work attitudes: Moderating effects of mentoring others with Nigerian employees
963
Career preferences and the work–family balance in medicine: gender differences among medical specialists
964
Career profile of dentists in Saudi Arabia
965
Career progress of recent tourism graduates
966
Career prospects for female university researchers have not improved
967
Career Research Productivity Patterns of Marketing Academicians
968
Career Selection: Role of Parent’s Profession, Mass Media and Personal Choice
969
Career Self-Efficacy Among African-American Female Adolescents
970
Career skills gained from an international equine experience
971
Career stress responses among hospitality employees
972
Career Women as a Role Model in the Formation of Morals
973
Career, experience and returns to human capital: is the dual labour market hypothesis relevant for the UK?
974
Careers and clusters: analyzing the career network dynamic of biotechnology clusters
975
Careers and human resource management—a European perspective
976
Careers and lives socialization, structural lag, and gendered ambivalence
977
Careers and mortality in France: evidence on how far occupational mobility predicts differentiated risks
978
Careers in Medicine or what do you want when you grow up?
979
Careers in science: policy issues according to Nature and Science editorials
980
Careers in the next millennium: directions for future research
981
Careers within careers: Reconceptualizing the nature of career anchors and their consequence
982
Careful considerations when reporting and evaluating the grey water footprint of products
983
Careful Co-Planning for Effective Team Teaching in Mathematics
984
Careful naming of disorders
985
Careful partial harvesting in conservation stands and retention of large oaks favour oak regeneration Original Research Article
986
Care-full markets? A reply to John Christman and Veronica Crossa
987
Caregiver and peer responses to children with language and motor disabilities in inclusive preschool programs
988
Caregiver attributions are not just for children: Evidence for generalized low power schemas
989
Caregiver burden among Iranian heart failure family caregivers: A descriptive, exploratory, qualitative study
990
Caregiver burden among Japanese informal caregivers of cognitively impaired elderly in community settings
991
Caregiver Burden among Parents of Hearing Impaired and Intel- lectually Disabled Children in Pakistan
992
Caregiver burden and coping
993
Caregiver burden and disability in somatization disorder
994
Caregiver burden and health promotion
995
Caregiver Burden and Its Associated Factors in Caregivers of Children and Adolescents with Chronic Conditions
996
Caregiver Burden and its Determinants among the Family Members of Patients with Dementia in Iran
997
Caregiver burden and outcomes of caregiving of spouses of patients who undergo coronary artery bypass graft surgery
998
Caregiver Burden and Quality of Life among Caregivers of Cancer Patients in Ahvaz, 2021 - 2022: A Cross-Sectional Study
999
Caregiver burden and related factors in Iranian mothers of children with Attention-Deficit Hyperactivity Disorder
1000
Caregiver burden associated with behavioral and psychological symptoms of dementia (BPSD) in Taiwanese elderly
بازگشت